The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Management of metastatic castration-resistant prostate cancer (mCRPC) at the Veterans Affairs Healthcare System (VAHCS): A real-world assessment of patient characteristics and treatment across lines of therapy.
 
Renning Zheng
Research Funding - Janssen Research & Development (Inst); Novartis (Inst)
 
Jennifer Nguyen
Employment - Novartis
Stock and Other Ownership Interests - Novartis
Travel, Accommodations, Expenses - Novartis
 
Jeetvan Patel
Employment - Merck (I); Novartis
Stock and Other Ownership Interests - Merck (I); Novartis
 
Vamsi Bollu
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Barinder Kang
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Amanda De Hoedt
Stock and Other Ownership Interests - Myovant Sciences
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Delfi Diagnostics (Inst); Exact Sciences (Inst); Ferring (Inst); Guardant Health (Inst); Janssen (Inst); Merck (Inst); Novartis (Inst); Photocure (Inst); Prostatype Genomics (Inst); Reinvestment Partners (Inst); Vir Biotechnology (Inst)
 
Joshua Parrish
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Blue Earth Diagnostics (Inst); Cedars-Sinai (Inst); Delfi Diagnostics (Inst); Diasorin (Inst); Exact Sciences (Inst); Ferring (Inst); Genomic Health (Inst); Guardant Health (Inst); Janssen (Inst); LungLife AI (Inst); MDxHealth (Inst); Merck (Inst); Myovant Sciences (Inst); Myriad Genetics (Inst); Novartis (Inst); Pfizer (Inst); Photocure (Inst); Prostatype Genomics (Inst); Reinvestment Partners (Inst); VIR Biotechnology (Inst)
 
Stirling Cummings
No Relationships to Disclose
 
Stephen Freedland
Employment - Genomic Health (I)
Stock and Other Ownership Interests - Caper Labs; Hessian Labs
Consulting or Advisory Role - A3P Biomedical; Astellas Pharma; AstraZeneca; Bayer; Caper Labs; Clovis Oncology; Dendreon; Exact Sciences; Exosome Diagnostics; Ferring; Hessian Labs; Janssen Biotech; Lilly; LynxDx; Merck; Myovant Sciences; Novartis; Pfizer; Sanofi; Tempus
Speakers' Bureau - Astellas Pharma; AstraZeneca; Pfizer; Sanofi
Research Funding - Bayer (Inst); Diasorin; GenomeDx (Inst); Janssen Biotech (Inst); MDxHealth (Inst); Merck; Myriad Genetics (Inst); OPKO Diagnostics (Inst); Progenika (Inst)
Travel, Accommodations, Expenses - Sanofi
 
Anthony Nguyen
No Relationships to Disclose